Hematology. American Society of Hematology. Education ProgramHumansLeukemiaMyeloidAcuteNucleophosmin
Using genomics to refine pediatric AML risk stratification.
Martina Pigazzi, Soheil Meshinchi, Franco Locatelli
Published: 202510.1182/hematology.2025000714
Abstract
In the past 20 years, advances in genomic technologies have greatly improved our understanding of pediatric acute myeloid leukemia (AML). Today, cytogenetic tests can detect structural changes in approximately 75% of cases and remain a main tool for…
Preview only. Read the full abstract at the source